老年患者术后新处方加巴喷丁的长期使用情况
该研究基于2013-2018年Medicare 20%样本,纳入65岁以上无既往加巴喷丁类使用史的非白内障手术患者,发现术后新处方加巴喷丁者中22%在出院90天后仍有处方续配。女性、较高Charlson共病评分、出院时及90天后阿片处方、较高照护复杂度与长期使用相关。
要点
- 术后新处方加巴喷丁的老年患者中22%在出院90天后仍续配。
- 女性、更高共病评分、出院时及90天后阿片处方、更高照护复杂度与长期使用相关。
- 长期使用加巴喷丁增加不良药物事件和多重用药风险。
核心结论
- 超过五分之一的术后新处方加巴喷丁老年患者在出院90天后仍续配,尤其见于共病更多和同时长期使用阿片者,增加不良药物事件和多重用药风险。
研究设计与样本
- 研究合并2013-2018年Medicare Carrier、MedPAR和Outpatient Files的20%样本与Part D数据。
- 纳入65岁以上、无既往加巴喷丁类使用史、接受常见非白内障手术的患者,排除出院去向为安宁疗护或死亡者。
- 术后新处方加巴喷丁定义为手术前7天至出院后7天内有配药记录。
- 主要结局为长期使用加巴喷丁,定义为出院90天后仍有配药。
- 采用logistic回归模型识别长期使用的危险因素,调整手术类型、患者特征、住院时长、出院去向和照护复杂度。
主要发现
- 共17,970例患者(占所有符合条件患者的3%)术后新处方加巴喷丁,平均年龄73岁,62%为女性。
- 最常见手术为全膝关节置换(45%)和全髋关节置换(21%)。
- 长期使用加巴喷丁发生率为22%。
- 长期使用组更可能为女性(64% vs. 61%)、非白人(14% vs. 12%)、同时长期使用阿片(44% vs. 18%)和接受急诊手术(8% vs. 4%)。
- 多变量分析显示,女性、较高Charlson共病评分、出院时及90天后有阿片处方、较高照护复杂度与加巴喷丁长期使用相关。
临床怎么用
- 对术后新处方加巴喷丁的老年患者,应关注女性、共病较多、出院时及90天后仍用阿片、照护复杂度较高者,警惕长期使用风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgeons have made substantial efforts to decrease postoperative opioid prescribing, largely because it can lead to prolonged use. These efforts include adoption of non-opioid pain medication including gabapentin. Like opioids, gabapentin use may be prolonged, increasing the risk of altered mental status and even overdose and death when taken concurrently with opioids. However, little is known about postoperative prolonged use of gabapentin in older adults. METHODS: We merged a 20% sample of Medicare Carrier, MedPAR and Outpatient Files with Part D for 2013-2018. We included patients >65 years old without prior gabapentinoid use who underwent common non-cataract surgical procedures. We defined new postoperative gabapentin as fills for 7 days before surgery until 7 days after discharge. We excluded patients whose discharge disposition was hospice or death. The primary outcome was prolonged use of gabapentin, defined as a fill>90 days after discharge. To identify risk factors for prolonged use, we constructed logistic regression models, adjusted for procedure and patient characteristics, length of stay, disposition location, and care complexity. RESULTS: Overall, 17,970 patients (3% of all eligible patients) had a new prescription for gabapentin after surgery. Of these, the mean age was 73 years old and 62% were female. The most common procedures were total knee (45%) and total hip (21%) replacements. Prolonged use occurred in 22%. Those with prolonged use were more likely to be women (64% vs. 61%), be non-White (14% vs. 12%), have concurrent prolonged opioid use (44% vs. 18%), and have undergone emergency surgery (8% vs. 4%). On multivariable analysis, being female, having a higher Charlson comorbidity score, having an opioid prescription at discharge and at >90 days and having a higher care complexity were associated with prolonged use of gabapentin. CONCLUSIONS: More than one-fifth of older adults prescribed gabapentin postoperatively filled a prescription >90 days after discharge, especially among patients with more comorbidities and concurrent prolonged opioid use, increasing the risk of adverse drug events and polypharmacy.
引用
- Bongiovanni T, Gan S, Finlayson E, et al. Prolonged use of newly prescribed gabapentin after surgery. J Am Geriatr Soc. 2022. PMID: 36000860. doi:10.1111/jgs.18005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。